Mascoma’s MGT yeast wins key OK from FDA; higher yields, enzyme savings in sight for ethanol producers
In New Hampshire, Mascoma announced today that FDA, after scientific review, supports the use of the Mascoma Grain Technology yeast product as a processing aid in the production of animal feed, which is a by-product of the corn ethanol conversion process.
MGT is the first commercial application of Mascoma’s proprietary consolidated bioprocessing (CBP) technology platform and is designed as a drop-in substitute for conventional fermenting yeast.
MGT lowers costs for corn ethanol producers by alleviating the need to purchase most of the enzymes currently used in corn ethanol production. Plus, pilot-scale test runs of the next generation MGT product, as conducted by ICM, demonstrated ethanol yield improvements of up to 3.4%. The MGT product is manufactured and distributed by Lallemand Ethanol Technology (LET) and jointly marketed and sold by Mascoma and LET.
More background on the story from the Digest
Category: Producer News